Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Jun;6(6):1413-1424.
doi: 10.1002/hep4.1890. Epub 2022 Jan 21.

Features of Cirrhotic Cardiomyopathy Early in the Lives of Infants With Biliary Atresia Correlate With Outcomes Following Kasai Portoenterostomy

Affiliations
Multicenter Study

Features of Cirrhotic Cardiomyopathy Early in the Lives of Infants With Biliary Atresia Correlate With Outcomes Following Kasai Portoenterostomy

Jhavene Morrison et al. Hepatol Commun. 2022 Jun.

Abstract

Cirrhotic cardiomyopathy (CCM), detected during two-dimensional echocardiography (2DE), is prevalent in patients with biliary atresia (BA) awaiting transplant. Whether CCM occurs early in the lives of infants with BA is unknown. The aim of this study was to explore the incidence and consequence of CCM in patients with BA, focusing on the earliest ages when 2DE was performed. A cohort of 78 patients with BA at a single center underwent 2DE (median age = 132 days) during the first year of life. Left ventricular mass index (LVMI) to upper limit of normal (ULN) ratio ≥ 1.0 was present in 60% of patients who never underwent Kasai portoenterostomy (KPE; n = 15), 49% with nondraining KPE (n = 41), and 21% with draining KPE (n = 19). Patients with a draining KPE (median age at 2DE = 72 days) had a lower LVMI/ULN ratio (0.75 [interquartile range [IQR] 0.70, 0.91]) compared to those with a nondraining KPE (0.99 [IQR 0.78, 1.17] median age of 141 days; P = 0.012). In those whose 2DE was performed within 7 days of KPE (n = 19, median age of 61 days), the LVMI/ULN ratio was lower in those with a future draining KPE (0.73 [IQR 0.66, 0.75]) compared to the group with a future nondraining KPE (1.03 [IQR 0.88, 1.08], P = 0.002). Logistic regression modeling revealed LVMI/ULN ratio ≥ 1.0 as a predictor of KPE outcome, with an odds ratio of 16.7 (95% confidence interval 1.36-204; P = 0.028) for a future nondraining KPE compared to those with a LVMI/ULN ratio < 1.0. Conclusion: 2DE early in the lives of patients with BA revealed features of CCM that correlated with future outcomes. If validated in a multicenter study, this could lead to 2DE as a useful clinical tool in the care of infants with BA.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Patients with BA selected for analysis. Consort diagram illustrating selection of patients with BA and a 2DE done within the first year of life during the study period January 2010 to December 2018.
FIG. 2
FIG. 2
(A) Age at 2DE performed within the first year of life in patients with BA (P = 0.001). (B) LVMI/ULN ratio in patients with BA is significantly higher in patients with a nondraining KPE compared to those with a draining KPE. There is no statistical difference between nondraining KPE and no KPE.
FIG. 3
FIG. 3
The difference in LVMI/ULN ratio between draining and nondraining KPE in the early 2DE subgroup remains statistically significant when there is no difference in age at 2DE. (A) Age at 2DE in the early 2DE subgroup (P = 0.09). (B) The LVMI/ULN ratio remains significantly different between nondraining and draining KPE in the early 2DE subgroup (P = 0.002).

References

    1. Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953;32:1025‐1033. - PMC - PubMed
    1. Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med 1989;151:530‐535. - PMC - PubMed
    1. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996;24:451‐459. - PubMed
    1. Blendis L, Wong F. Is there a cirrhotic cardiomyopathy? Am J Gastroenterol 2000;95:3026‐3028. - PubMed
    1. Wong F. Cirrhotic cardiomyopathy. Hepatol Int 2009;3:294‐304. - PMC - PubMed

Publication types